MTOR and head and neck squamous cell carcinoma: Studies have revealed a similar phenomenon in patients with HNSCC, indicating that overexpressed proteins in the PI3K/AKT/mTOR signaling pathway may be used as good prognostic biomarkers, including p-mTOR, p-PI3K, and p-S6 [27].